Yen‐Jung Chiu

The share of this author’s assessed papers carrying a ⚑ flag. A concentration is a prompt for expert review — never, on its own, a determination about the person.

Collaborators, sized by shared output and coloured by their own reproducibility (green = high, red = low). Click a node to open their card. A pattern is a prompt for review, never a determination.

How this author’s assessed papers reproduced — the outcome of reproduction attempts, not a judgement of the person. Coverage is partial and grows over time.

Assessed papers (1)

• HArmonized single-cell RNA-seq Cell type Assisted Deconvolution (HASCAD).
  2023 L1 67/100

1 assessed by us (0 reproduced) · 20 not yet assessed — every PubMed paper on record, linked below.

• LIMPACAT: Multi-omics attention transformer for immune prediction in liver cancer using whole-slide imaging ↗

  PLoS ONE · 2026 · PMID 41511965
  not yet assessed
• Comparative Evaluation of Drug Response Metrics for Predicting Cancer Sensitivity Using Transcriptomic Profiles ↗

  BIO Web of Conferences · 2026
  not yet assessed
• Comparative Evaluation of Drug Response Metrics for Predicting Cancer Sensitivity Using Transcriptomic Profiles ↗

  Springer Link (Chiba Institute of Technology) · 2026
  not yet assessed
• Machine Learning-Driven Transcriptome Analysis of Keratoconus for Predictive Biomarker Identification ↗

  Biomedicines · 2025 · PMID 40426861
  not yet assessed
• Bridging VAE-Derived Latent Gene Representations and Graph Neural Networks for Improved Drug Response Prediction ↗

  2025 · PMID 41337413
  not yet assessed
• Mutation-Based Survival Prediction in Hepatocellular Carcinoma: A Genomic Alternative Matching Transcriptomic Approaches ↗

  2025
  not yet assessed
• Chunking for Medical Knowledge Dataset Construction and LLM-Based Question Answering ↗

  2025
  not yet assessed
• Automated medication verification system (AMVS): System based on edge detection and CNN classification drug on embedded systems ↗

  Heliyon · 2024 · PMID 38742071
  not yet assessed
• Enhancing Medical Diagnosis with Fine-Tuned Large Language Models: Addressing Cardiogenic Pulmonary Edema (CPE) ↗

  2024
  not yet assessed
• LIMPACAT : Multi-Omics Attention Transformer for Immune Prediction in Liver Cancer Using Whole-Slide Imaging ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2024
  not yet assessed
• HArmonized single-cell RNA-seq Cell type Assisted Deconvolution (HASCAD)

  BMC Medical Genomics · 2023 · PMID 37907883
  L1 67/100
• Deconvolution of bulk gene expression profiles reveals the association between immune cell polarization and the prognosis of hepatocellular carcinoma patients ↗

  Cancer Medicine · 2023 · PMID 37366298
  not yet assessed
• Using Deep Learning and Adaptive Window Adjustment to Facilitate the Detection of Pulmonary Edema Detection in Chest X-Rays ↗

  2023
  not yet assessed
• TSSUNet-MB – ab initio identification of σ70 promoter transcription start sites in Escherichia coli using deep multitask learning ↗

  Computational Biology and Chemistry · 2023 · PMID 37327560
  not yet assessed
• FLAg: An automated client-independent federated learning system on HPC for digital pathology slice training ↗

  2023
  not yet assessed
• TSSNet – A Deep Neural Network Model for Predicting Prokaryotic Transcription Start Sites ↗

  2022
  not yet assessed
• Time Series Multi-task Learning for Prognosis of MICU and SICU ↗

  International Journal of Clinical Medicine and Bioengineering · 2022
  not yet assessed
• Improved cell composition deconvolution method of bulk gene expression profiles to quantify subsets of immune cells ↗

  BMC Medical Genomics · 2019 · PMID 31856824
  not yet assessed
• MOESM2 of Improved cell composition deconvolution method of bulk gene expression profiles to quantify subsets of immune cells ↗

  Open MIND · 2019
  not yet assessed
• Nesfatin-1/Nucleobindin-2 enhances cell migration, invasion, and epithelial-mesenchymal transition via LKB1/AMPK/TORC1/ZEB1 pathways in colon cancer ↗

  Oncotarget · 2016 · PMID 27150059
  not yet assessed
• Chemokine (C-C Motif) Ligand 5 is Involved in Tumor-Associated Dendritic Cell-Mediated Colon Cancer Progression Through Non-Coding RNA MALAT-1 ↗

  Journal of Cellular Physiology · 2014 · PMID 25546229
  not yet assessed